Dear Dynamic Wealth Report Reader,
Occasionally here at the Dynamic Wealth Report we come across investing ideas that are so compelling, we need to tell you about them ASAP.
And we've recently found such an opportunity...
It's a small biotech company that's developing an innovative drug that may target and kill cancer cells.
Now look, we know that nearly EVERY biotech company is trying to find a "cure" for cancer...
But this company Robert is targeting is going about it in a different way than most other "run of the mill" biotech firms.
It's too involved to go into detail here, but I STRONGLY suggest you take a look at Robert's write-up on this company.
He's releasing his recommendation tomorrow in his Biotech Supertrader newsletter.
Click here to see what it's all about... and discover the name of the exciting stock I'm talking about!
Sincerely,
John Alexander, Associate Editor
Dynamic Wealth Report | | | | | | Copyright 2012 Hyperion Financial Group, LLC. All Rights Reserved. Protected by copyright laws of the United States and international treaties. This email may only be used pursuant to the subscription agreement controlling use of the Dynamic Wealth Report website and any reproduction, copying, or redistribution of this email or its contents, in whole or in part, is strictly prohibited without the express written permission of Hyperion Financial Group, LLC.
LEGAL DISCLAIMER: Neither Hyperion Financial Group LLC nor any of it's employees, contractors or officers are registered investment advisors or a Broker/Dealer. As such, Hyperion Financial Group, LLC does not offer or provide personalized investment advice. Although Hyperion Financial Group, LLC employees and contractors may answer general customer service questions, they are not licensed under securities laws to address your particular investment situation. Nothing in this report, nor any communication by our employees or contractors to you should be considered personalized investment advice.
Owners and writers may have positions in the securities that are discussed. However, no associated employees or contractors may intentionally engage in any transaction that directly or indirectly competes with the interests of our subscribers. We accept no compensation from any companies mentioned in our reports.
Past performance is no guarantee of future results. All information is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor is it to be construed as a recommendation to buy, hold or sell any security. All opinions, analyses and information contained herein are based on sources believed to be reliable and written in good faith, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. Investments recommended in this publication should only be made after consulting with your financial advisor. | |
No comments:
Post a Comment
Keep a civil tongue.